What You Should Know:
- NationsBenefits®, a healthcare fintech, supplemental benefits, and outcomes platform, and Walmart, the world’s largest retailer announced they are continuing to work together to revolutionize how health plan members access essential benefits through innovative, tech-powered tools.
- The ongoing collaboration prominently features NationsBenefits’ proprietary Basket Analyzer Service (BAS) and the Walmart Everyday Health Signals™ program, which leverages
Read More
Corti Joins Coalition for Health AI to Advance Responsible and Safe AI in Healthcare
What You Should Know:
- Corti, an AI infrastructure provider for healthcare, announced it is joining the Coalition for Health AI (CHAI). This move signifies Corti's commitment to collaborating on the development of best practices and frameworks to foster innovation, safety, and security for artificial intelligence in the health sector.
- CHAI is an industry-led coalition that brings together a diverse group of stakeholders, including health systems, patient advocates, researchers,
Read More
Walmart Unveils Digital Health Innovations to Enhance Medicare Advantage Benefit Use and Promote Healthier Eating
What You Should Know:
- Walmart today announced new digital innovations designed to transform the healthcare shopping experience, specifically aiding customers in maximizing their Medicare Advantage supplemental benefits.
- In a first for retail, select customers can now easily identify plan-specific, benefits-eligible products while shopping on Walmart.com and the Walmart app. Alongside this, Walmart is rolling out "Everyday Health Signals," a new AI-powered digital platform
Read More
AssistIQ Secures $11.5M to Transform Hospital Supply Chains with AI
What You Should Know:
- AssistIQ, an AI company utilizing computer vision to revolutionize how hospitals manage surgical and procedural supply chains secures $11.5M in Series A funding round led by Battery Ventures, with participation from return investor Tamarind Hill. With this funding, Battery Ventures Principal Brandon Gleklen will join AssistIQ’s Board of Directors.
- The company’s platform is gaining traction across academic and community hospitals, capturing every item used in
Read More
Kyron.bio Secures $6.2M to Optimize Biologic Drug Development with Precision Glycan Engineering
What You Should Know:
- Biotechnology company kyron.bio announced the successful closing of a $6.2M (€5.5M) seed funding round aimed at solving critical challenges in biologic drug development, specifically varying efficacy and the dangers of side effects.
- The round was led by HCVC, with participation from Verve Ventures, Entrepreneurs First, Saras Capital, and numerous reputable angel investors.
- The funds will be used to accelerate the development of kyron.bio’s proprietary
Read More
Abridge Launches AI-Powered Pediatric Well Visit Note Type
What You Should Know:
- Abridge, a company specializing in AI-powered clinical documentation, announced the launch of a new pediatric well visit note type within its platform.
- The enhancement leverages Abridge's advanced Contextual Reasoning Engine to automatically generate clinically useful and billable documentation tailored to the unique, structured needs of pediatric well visits, which vary significantly by a child's age and developmental stage.
- The new feature was
Read More
Helix Launches New PGx Tests for Chemotherapy (DPYD) & Alzheimer’s Drug (APOE) Safety
What You Should Know:
- Helix, a leader in precision health announced the release of a new suite of pharmacogenomics (PGx) tests designed to enhance personalized care, particularly in oncology and neurology.
- Key among these are a test to identify patients with DPYD gene variants who may be at increased risk for severe side effects from certain chemotherapies, and a first-of-its-kind test that assesses APOE status relevant to newly available Alzheimer's drugs.
Tailoring
Read More
Drug Diversion in Hospitals Persists as an Underreported “Elephant in the Room”
What You Should Know:
- Despite increased investments in detection programs, drug diversion—the illegal obtaining of prescription drugs by healthcare staff—continues to be a significant and often underreported issue within U.S. hospitals and health systems, according to the fifth edition of the "State of Drug Diversion" report released by Wolters Kluwer Health.
- The comprehensive survey of nurse leaders, pharmacists, risk managers, and drug diversion program leaders reveals that
Read More
German Bionic Unveils First True Augmented AI Exoskeleton, Exia
What You Should Know:
- German Bionic, the robotics pioneer renowned for first connecting exoskeletons to the cloud, launches Exia – its most advanced wearable device to date and the world’s first exoskeleton powered end-to-end by true Augmented AI.
- Informed by insights from billions of real-world motion data points collected across industries including manufacturing, logistics, retail, and healthcare, Exia aims to set a new benchmark for strength, intelligence, and
Read More
Brooklyn Health Secures $6.5M to Expand AI-Powered Precision for Clinical Trial Endpoints
What You Should Know:
- Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health announced it has secured $6.5M in seed funding led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio, Blue Falcon Capital, and others.
- The funding coincides with the company's debut of its new electronic clinical outcome assessment (eCOA) solution, Willis. Willis
Read More
